Cáncer de recto; Cirugía rectal; Neuromodulación sacraCàncer de recte; Cirurgia rectal; Neuromodulació sacraRectal cancer; Rectal surgery; Sacral neuromodulatio
OBJECTIVE: To summarize the evidence in the literature about rehabilitative treatments that reduce l...
MD (Res) ThesisIntroduction The assessment and management of rectal cancer is complex, involving cl...
Background: Low anterior resection (LAR) with total mesorectal excision (TME) for mid and low rectal...
Introduction: A total of 60–80% of patients undergoing rectal resection (mostly as a treatment for r...
M. Gladman is part of the Lars International Collaborative GroupBACKGROUND: Low anterior resection s...
SummaryBackground/ObjectiveDefective defecation function, also known as low anterior resection syndr...
Many patients develop a variety of bowel dysfunction after sphincter preserving surgeries (SPS) for ...
Purpose Oncological outcomes following rectal cancer surgery have improved significantly over recent...
BACKGROUND: In Europe, colorectal cancer is the second most common cancer in women and third most co...
Little is known about the pathophysiology of low anterior resection syndrome (LARS), and evidence co...
Aim Low Anterior Resection Syndrome (LARS) following rectal cancer surgery impairs the patient's qua...
Supplemental Digital Content is available in the text. The aim of this collaboration was to develop ...
Background: With the increasing use of low anterior resection (LAR) to treat rectal cancer and avoid...
The objective of the study Rectal cancer represents a public health issue, considering the increased...
Defective defecation function, also known as low anterior resection syndrome (LARS), is a common pro...
OBJECTIVE: To summarize the evidence in the literature about rehabilitative treatments that reduce l...
MD (Res) ThesisIntroduction The assessment and management of rectal cancer is complex, involving cl...
Background: Low anterior resection (LAR) with total mesorectal excision (TME) for mid and low rectal...
Introduction: A total of 60–80% of patients undergoing rectal resection (mostly as a treatment for r...
M. Gladman is part of the Lars International Collaborative GroupBACKGROUND: Low anterior resection s...
SummaryBackground/ObjectiveDefective defecation function, also known as low anterior resection syndr...
Many patients develop a variety of bowel dysfunction after sphincter preserving surgeries (SPS) for ...
Purpose Oncological outcomes following rectal cancer surgery have improved significantly over recent...
BACKGROUND: In Europe, colorectal cancer is the second most common cancer in women and third most co...
Little is known about the pathophysiology of low anterior resection syndrome (LARS), and evidence co...
Aim Low Anterior Resection Syndrome (LARS) following rectal cancer surgery impairs the patient's qua...
Supplemental Digital Content is available in the text. The aim of this collaboration was to develop ...
Background: With the increasing use of low anterior resection (LAR) to treat rectal cancer and avoid...
The objective of the study Rectal cancer represents a public health issue, considering the increased...
Defective defecation function, also known as low anterior resection syndrome (LARS), is a common pro...
OBJECTIVE: To summarize the evidence in the literature about rehabilitative treatments that reduce l...
MD (Res) ThesisIntroduction The assessment and management of rectal cancer is complex, involving cl...
Background: Low anterior resection (LAR) with total mesorectal excision (TME) for mid and low rectal...
DOI
Add to ORKG